Last updated on July 2019

An Exploratory Study of the Effects of Nivolumab Combined With Ipilimumab in Patients With Treatment-Naive Stage IV or Recurrent Non-Small Cell Lung Cancer (NSCLC)


Brief description of study

The purpose of this study is to explore the possible links between participant characteristics and their cancer, with how effective the combination of nivolumab with ipilimumab is, in participants with Stage IV or recurrent Non-Small Cell Lung Cancer (NSCLC).

Clinical Study Identifier: NCT03001882

Find a site near you

Start Over

Local Institution

Haine Saint Paul, Belgium
  Connect »